stock_MYL r_up	all:1 people:1 have:1 discussions:1 close:1 makers:1 no:1 three:1 citing:1 going:1 generics:1 branded:1 's:2 interest:1 business:1 but:1 reported:1 active:1 buying:1 --:1 matter:1 time:1
stock_MYL r_down	inspectors:1 pharmaceutical:1 plant:1 met:1 appear:1 ingredients:1 according:1 make:1 required:1 results:1 drug:1 standards:1 raw:1 materials:1 test:1 active:1
stock_MYL r_down	2014:1 beyond:1 says:1 pricing:1 improve:1
stock_MYL r_up	's:1 generic:1 marketing:1 company:1 court:1 drug:2 version:1 can:1 performance:1 not:1 making:1 its:1 ruled:1
stock_MYL r_up	sending:1 said:1 deal:1 would:1 both:1 surge:1 buy:1 sharply:1 buyout:1 stocks:1 pharmaceutical:1 higher:1
stock_MYL r_up	billion:1 25:1 's:1 $:1 deal:1 rival:1 company:1 takeovers:1 drug:1 appetite:1 hearty:1 swallow:1 has:1 maker:1 acquisition:1 shows:1
stock_MYL r_up	steel:1 announcement:1 store:1 impose:1 jewelry:1 deal:1 soars:2 rival:1 pipes:1 after:1 slumps:1 down:1 not:1 while:1 decided:1 ruling:1 following:1 chain:1 tariff:1 tariffs:1 buying:1
stock_MYL r_down	shortages:1 short:2 dogged:1 prompted:2 supply:2 recall:2 lapse:2 resume:2 drug:3 one:1 past:2 shipping:2 have:1 year:2 years:1 many:1 industry:1 after:2 recent:1
stock_MYL r_up	streak:1 dovish:1 investors:1 soars:1 reporting:1 surrenders:1 down:1 cold:1 before:1 closes:1 surges:1 winning:1 rosy:1 quarterly:1 500:2 stock:1 snaps:1 after:2 gains:2 market’s:1 earnings:1 company:1 welcome:1 benchmark:1 water:1 remarks:1 analyst:1 earlier:1 record:2 while:1 edge:1 push:1 fresh:1 better-than-expected:1 view:1
stock_MYL r_down	billion:1 software:1 valued:1 off:1 cloud-software:1 business:1 multibillion-dollar:1 almost:1 starting:1 companies:1 40:1 wave:1 second:1 command:1 take:1 rich:1 online:1 valuations:1 more:1 specialized:1 $:1
stock_MYL r_up	run:1 bullish:1 today’s:1 its:1 course:1 remain:1 backdrop:1 bull:1 based:1 skepticism:1 500’s:1 technicals:1 market:2 five-year:1
stock_MYL r_down	shareholders:1 may:1 price:1 30:1 sales:1 value:1 finally:1 suffering:1 new:1 helm:1 stabilizing:1 reward:1
stock_MYL r_down	fourth-quarter:1 weaker:1 version:1 revenue:1 related:1 trade:1 '':1 rate:1 session:1 drug:1 year:1 2.2:1 edged:1 margins:1 energy-efficiency:1 its:2 plans:1 generic:1 said:3 court:1 raise:1 would:1 federal:1 shares:1 increase:1 start:1 offers:1 growth:1 earnings:1 which:1 expected:1 nine-year:1 company:1 ``:1 selling:1 's:5 video-streaming:1 price:1 free:1 99:1 membership:1 fell:1 favorable:1 offset:1 such:1 69:1 79:1 $:3 prime:1 renewable-energy:1 service:1 premarket:1 companies:1 up:1 shipping:2 expedited:1 patent:1 perks:1 actively:1 ruling:1 history:1 called:1 first:1
stock_MYL r_down	television:1 gains:2 deal:1 robust:1 demand:1 likely:1 offering:1 buzz:1 new:3 chatter:1 talk:2
stock_MYL r_up	1.2:1 bounce:1 session:1 caution:1 follow:1 still:1 dented:1 which:1 finish:1 gains:1 week’s:1 but:1 lows:1 fall:1 prices:1 news:1 stocks:2 day:1 lower:1 off:1 last:1 light:1 prevails:1 drop:1 economic:1 skids:1
stock_MYL r_down	awarded:1 consulting:1 benefited:1 slipped:1 revenue:1 certain:1 expectations:1 ``:1 raised:1 related:1 trade:1 '':1 case:1 full-year:1 session:1 tablets:1 drug:1 further:1 jury:3 forecast:1 seek:1 its:5 litigation:1 said:6 $:3 would:1 generic:1 pay:1 top:1 relief:1 outsourcing:1 shares:2 improvement:1 favor:1 intends:1 2:1 earnings:2 premarket:1 between:1 expected:1 9.5:1 ruled:1 damages:1 firm:1 billion:1 all:1 settle:1 's:1 business:1 company:1 million:1 pleased:1 protect:1 intellectual:1 lawsuit:1 second-quarter:1 missed:1 fiscal:1 regarding:1 grew:1 agreements:2 rights:2 companies:1 against:1 antidepressant:1 actively:1 verdict:1 2007:1 property:1 slightly:1 maker:1 additional:1
stock_MYL r_up	one:1 all:1 own:1 's:1 champion:1 generic:1 brand-name:1 protect:1 but:1 nation:1 drugs:1 way:1 products:1 go:1 known:1 court:1 highest:1 its:1
stock_MYL r_up	blockbuster:1 consider:1 patent:1 agreed:1 drug:1 its:1 multiple-sclerosis:1 ruling:1 appeal:1 company:1
stock_MYL r_down	pharmaceutical:1 tie-up:1 's:2 would:1 people:1 familiar:1 industry:1 according:1 drug:1 looking:1 matter:1 lower:1 could:1 taxes:1 company:1 maker:1 buying:1 latest:1
stock_MYL r_up	fourth-quarter:1 deal:1 revenue:2 doing:1 correction:1 idea:1 private:1 eyeing:1 down:1 actively:1 businesses:1 looks:1 news:1 accounting:1 11th:1 processor:1 its:1 finance:1 pharmaceutical:1 said:1 group:1 $:1 5.7:1 generic:1 jumped:1 recorded:1 two:1 shares:2 your:1 pharmaceuticals:1 ideal:1 combine:1 earnings:2 interest:1 funds:1 expected:1 proposal:1 has:2 might:1 strength:1 higher:1 eyes:1 pushing:1 's:6 premarket:1 beat:1 big:1 company:2 were:2 results:1 specialty:2 rejected:1 sales:1 biggest:1 hurt:1 takeover:1 but:1 timing:1 4.1:1 hedge:1 trade:1 continued:1 expectations:1 fiscal:2 jump:1 grew:1 third-quarter:1 equity:1 credit-card:1 morning:1 companies:1 drug:2 flagged:1 n't:1 below:1 session:1 expenses:1 logic:1 banks:1 including:1 maker:1 acquisition:1 dropped:1
stock_MYL r_down	billion:2 pharmaceutical:1 buy:2 $:4 5.6:4 --:1 agreed:2 specialty:2 cash:2 consolidation:1 sign:1 business:1 pharmaceuticals:1 scale:1 expected:1 deal:1 latest:1 company:1 diversification:1 expand:1 stock:2
stock_MYL r_down	settling:1 said:1 's:2 patent:1 after:1 able:1 version:1 year:1 release:1 end:1 its:1 dispute:1
stock_MYL r_up	litigation:1 all:1 said:1 license:1 painkiller:1 patent:1 marketing:1 over:1 earlier:1 start:1 its:1 generic:2 version:2 perhaps:1 has:2 settled:1 granted:1
stock_MYL r_up	billion:1 raised:1 $:1 bid:1 drug:1 maker:1 6.7:1 has:1 its:1
stock_MYL r_down	prospect:1 saying:1 says:1 into:1 stand-alone:1 outperforms:1 broader:1 market:1 again:1 merger:2 shares:1 pharmaceuticals:1 company:2 surges:1 tried:1 bid:1 sweetened:1 specialty:1 rejected:1 peer:1 rallying:1 prefers:1 up:1 drug:1 remain:1 maker:1 talk:1
stock_MYL r_up	criticism:2 spurred:1 deal:1 succeeds:1 betting:1 focus:1 years:1 player:1 legacy:1 rising:1 have:1 escape:1 tools:1 its:1 huge:1 gainers:1 harsh:1 technology:1 make:1 actually:1 biggest:1 strengths:1 500:1 more:1 gains:1 returning:1 big:1 blockbusters:1 nimble:1 takeover:1 pursuit:1 tanks:1 prices:1 one:1 response:1 arena:1 recovering:1 possibly:1 rival:1 could:1 spent:1 slumps:1 deals:1 aging:1 while:1 place:1 economies:1 fuel-cell:2 stock:1 corporate:1 executives:1
stock_MYL r_up	session:2 said:1 's:5 versions:1 generic:2 rival:1 companies:2 shares:2 trade:2 motion:1 drug:2 actively:2 multiple-sclerosis:1 dismissed:1 approval:1 expected:2 court:1 maker:1 block:1
stock_MYL r_up	premium:1 deals:1 shareholders:1 's:3 rejection:1 offer:1 may:1 company:1 share:1 inversion:1 per:1 down:1 55:1 takeover:1 turning:1 nearly:1 balk:1 stakes:1 normally:1 higher:1 shows:1
stock_MYL r_up	sell:1 said:1 court:1 painkiller:1 federal:1 decision:1 period:1 regulatory:1 version:1 allow:1 backed:1 's:1 has:1 company:1 generic:1
stock_MYL r_up	session:2 said:1 's:2 version:1 painkiller:1 generic:1 over:1 companies:2 sales:1 shares:2 trade:2 blockbuster:1 actively:2 expected:2 reached:1 settlement:1
stock_MYL r_down	appeals:1 held:1 even:1 unusual:1 suicide:1 court:1 her:1 federal:1 responsible:1 had:2 should:1 instance:1 denied:1 taken:1 pill:1 week:1 woman:1 's:1 though:1 bid:1 dismiss:1 filed:1 such:1 lawsuit:1 he:1 made:1 rival:1 drug:1 generic:1 claims:1 maker:1 husband:1
stock_MYL r_down	exists:1 pays:1 analysis:1 total:1 fine:1 makers:1 shareholders:1 suffer:1 requirements:1 rules:1 'yes:1 which:1 between:1 answer:1 new:1 violations:1 do:1 return:1 may:1 big:1 marketing:1 governing:1 shareholder:1 regulatory:2 such:1 manufacturing:1 comply:1 drug:2 suggests:1 practices:1 correlation:1 maker:1
stock_MYL r_up	managed:1 deal:1 some:1 have:1 pharmaceutical:1 $:1 46:1 least:1 current:1 scramble:1 company:1 buy:1 's:1 partners:1 tax:1 bid:1 rejected:1 stay:1 selective:1 advantages:1 address:1 come:1 billion:1 attempt:1 rival:1 companies:1 foreign:1 takeover:1 survey:1 maker:1 latest:1
stock_MYL r_down	raised:1 says:1 bring:1 second:1 growth:1 year:1 table:1 should:1 its:2 leg:1 pharmaceutical:1 upgrade:2 group:1 $:1 get:1 trademark:1 analyst:1 board:1 fourth:1 gets:2 today:1 more:1 sued:2 's:1 offer:1 infringement:1 company:1 negotiating:1 sharply:1 half:1 off:1 stocks:1 than:1 bank:1 billion:1 attempt:1 51:1 up:1 selling:1
stock_MYL r_down	help:1 point:1 51:1 tax:1 including:1 ink:1 premium:1 its:2 before:2 pharmaceutical:3 $:1 48:1 generic:1 offer:3 cross-border:1 delay:1 version:1 rates:1 medicine:1 crackdown:1 racing:1 fines:1 billion:1 them:1 's:1 increased:1 get:1 big:1 company:3 cheaper:1 producers:1 expected:1 five:1 gain:1 recent:1 paying:1 early:1 lower:1 made:1 most:1 these:1 traded:1 could:1 access:1 companies:2 drug:1 morning:1 deals:2 popular:1 done:1 corporate:1 first:1
stock_MYL r_up	developed:1 trade:1 session:1 through:1 its:2 giant:1 $:7 interesting:1 had:2 equity:1 dominated:1 has:1 all-stock:1 good:1 increased:1 seeking:1 beat:1 rebound:1 private:1 burden:1 hedge:1 prime:1 inversion:1 success:1 countries:1 54:2 companies:4 morning:1 deals:2 inversions:1 including:1 better-than-expected:1 beneficial:1 deal:6 trend:1 actively:1 close:2 closes:1 said:1 shares:1 enough:1 health:1 above:2 new:1 is…:1 announced:1 we:1 business:3 sold:1 advantages:1 17,000:2 news:2 100:1 industry:2 drug:1 efforts:1 traded:1 think:1 marked:1 one:1 throughout:1 your:1 pharmaceutical:2 would:2 pharmaceuticals:2 takeovers:1 two:1 been:1 their:1 rates:1 biggest:1 hottest:1 branded:1 markets:1 today:1 more:1 head:1 buy:1 mostly:1 drugs:2 funds:1 company:1 fore:1 purposes:1 expected:1 part:2 demand:1 than:1 twist:1 valued:1 publicly:1 these:1 generics:3 n't:1 closing:1 example:2 health-care:2 tax:5 ``:2 '':2 have:1 sells:1 seek:1 finance:1 sell:2 5.3:5 equities:1 lately:1 other:2 earnings:1 which:2 largest:1 you:1 's:3 transactions:1 includes:1 driven:1 flurry:1 coming:1 stocks:2 types:1 billion:5 purchase:1 lower:1 transaction:1 wins:1 traditional:1 portion:1 banks:1 overseas:1 corporate:1 talk:1 latest:2
stock_MYL r_up	sector:1 help:1 figure:1 revenue:1 being:2 relocation:1 over:1 sidestep:1 tax:3 shut:1 sign:1 '':1 report:1 say:2 fever:1 through:1 drug:1 unveiled:1 pitch:1 close:1 reached:1 seen:1 $:1 makers:1 pharmaceutical:1 cut:1 20:1 stands:1 puts:1 no:1 merger:1 banker:1 concerned:1 seeking:1 legislation:1 looking:1 their:3 only:1 much:1 rates:1 slash:1 tumbles:1 taken:1 2014:1 include:1 health-care:1 shows:1 wants:1 billion:1 ``:1 restricting:1 's:1 both:1 memo:1 practice:1 but:1 wave:2 slides:1 them:1 difficult:1 internal:1 not:1 estimate:1 one:1 abroad:2 recent:1 corporate-tax:1 down:1 has:1 clients:1 companies:3 according:1 taxes:1 foreign:1 deals:2 while:1 race:1 mergers:1 lose:1 inversions:2 advantages:1 bills:1 nearing:1 urging:1 gain:2
stock_MYL r_down	joins:1 just:1 over:2 jurisdiction:1 its:2 profitable:1 proposed:1 revenue:1 guaranteed:1 second-quarter:1 under:1 lawmakers:2 sent:1 earnings:1 them:3 government:1 rules:1 stop:1 preferred:1 they:1 immediately:1 desire:1 committees:1 name:1 companies:5 joined:1 inversions:1 tightening:1 mergers:1 up:1 year:1 2.2:1 out:1 closer:1 said:1 debate:2 looking:1 rewarding:1 led:1 business:1 step:1 engage:1 boards:1 ahead:1 reports:2 foreign:1 amount:1 action:1 urges:1 fleeing:1 another:1 corporations:1 would:1 legislation:3 rates:1 more:1 wants:1 ``:2 immediate:1 than:2 rush:1 look:1 edged:1 budget:1 limit:3 enact:1 growing:2 urging:3 give:1 pass:2 tax:4 purposes:2 '':2 sudden:1 need:1 moves:2 perform:1 pay:1 congressional:1 administration:3 incentive:1 also:1 take:1 really:1 's:4 though:1 may:3 earlier:1 stay:1 most:1 letter:1 why:1 salary:1 lower:1 minimize:1 drive:1 rather:1 costs:1 allow:1 diagnostics:1 overseas:4 order:1
stock_MYL r_down	private-equity:1 code:1 being:1 over:1 tax:1 held:1 set:1 including:1 talks:1 $:1 rivals:1 potential:1 firms:1 has:1 abusing:1 drugs:1 believe:1 billion:1 valued:1 older:1 companies:1 sale:1 drug:1 n't:1 absurd:1 claims:1 maker:1
stock_MYL r_up	deal:1 tax:2 one:1 rate:1 reached:1 yet:1 its:1 $:2 spending:1 writes:1 fight:1 largest:1 has:1 breaks:1 seeks:1 buy:1 company:1 date:1 investments:1 sad:1 buying:1 billion:1 lower:2 54:2 drug:1 foreign:1 deals:2 truth:1 rival:1 maker:1 tax-‘inversion’:1
stock_MYL r_down	tax:1 code:1 moved:1 avoid:1 practice:1 companies:1 taxes:1 try:1 put:1 heat:1 have:1 inversions:1 overseas:1 midterms:1 margins:1
stock_MYL r_down	says:1 unsustainable:1 deal:1 fleeing:1 tax:2 one:1 done:1 corporations:1 its:2 pharmaceutical:1 giant:1 $:1 writes:1 least:1 quickly:1 failed:1 earnings:1 way:1 has:1 until:1 buy:1 get:1 far:1 big:1 stop:1 120:1 pressure:1 quest:1 analyst:1 billion:1 rival:1 fixes:1 taxes:1 continue:1 so:1 inversions:1 corporate:1 laws:1
stock_MYL r_down	deals:1 mutual:1 these:1 funds:1 try:1 benefit:1 individual:1 can:1 stocks:1 corporate:1 choose:1
stock_MYL r_down	emerging:1 months:1 proved:1 investors:1 trend:1 agreed:1 move:1 tax:2 looks:1 into:1 its:3 pharmaceutical:2 $:2 three:1 cross-border:1 looking:1 drugs:1 fought:1 multibillion-dollar:1 stable:1 hottest:1 has:1 markets:1 bid:1 buy:2 's:3 wo:1 company:3 after:1 reach:1 possible:1 but:1 takeover:2 peer:2 such:1 expand:1 billion:2 lower:1 spurn:1 off:1 --:2 just:1 bill:1 n't:1 broaden:1 products:1 night:1 inversions:1 served:1 maker:1 comes:1
